LEM-S403

N/A

Report date: 2024/12/12 13:30:15
NMEFirst In Class

Base Information

Drug NameLEM-S403
Drug Alias NameLEM-S403
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsToll like receptor 9 agonists
TargetsToll like receptor 9Indoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLemonex Inc
China Registration ClassN/A

Develop Information

Active CompaniesLemonex Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A